Deals and Client Wins Maples BVI Advises Biohaven Pharmaceutical on up to US$950 million of New Funding

03 Sep 2020

Maples and Calder, the Maples Group's law firm was pleased to advise its longstanding client, Biohaven Pharmaceutical Holding Company Ltd ("Biohaven") on the British Virgin Islands (BVI) legal aspects of its US$500 million non-dilutive term loan with Sixth Street and its US$450 million funding agreement with Royalty Pharma.  These transactions relate to separate funding arrangements with Sixth Street and Royalty Pharma with both deals closing in August 2020. The new funding will be used, in part, for the development, promotion and commercial launch of NURTEC ODT, the company's latest FDA-approved migraine medication.

 

Chris Newton, a Corporate Partner based in the Group's BVI office worked alongside Associate, Amel Wehden and Chartered Legal Executive, Chloe Harris in advising Biohaven, a BVI entity that is listed on the New York Stock Exchange, and other entities within the group.

 

Commenting on the transaction, Chris said, "We were delighted to assist Biohaven in securing this funding which will support the delivery of NURTEC ODT to patients around the globe. This cash injection will help to support the long term success of Biohaven and we very much look forward to continuing to work with the Biohaven team as their business progresses."

 

A longstanding client of the Group, the BVI team has acted as Biohaven's legal adviser since its incorporation, advising on its IPO in 2017 as well as other funding arrangements and continues to advise the company on its corporate matters.

CONTACTS

bioImage

Chris Newton

Partner

+1 284 852 3043

bioImage

Chloe Harris

Chartered Legal Executive

+1 284 852 3033

bioImage

Amel Wehden

Associate

+1 284 852 3034

*
*
*
*


Please note that your email may be received and read by other Maples Group employees in addition to your intended recipient.

The use of this form does not create an attorney-client relationship and information submitted will not necessarily be treated as privileged or confidential, nor will it prevent us from accepting related instructions on behalf of others. Do not send us any information regarding any current or potential legal matters until your proposed engagement of us as legal counsel has been agreed and confirmed by us in writing.

*
*
*

Please note that your email may be received and read by other Maples Group employees in addition to your intended recipient.

Related

Deals

Maples Advises on Restructuring Deal of the Year 2020

Maples and Calder, the Maples Group’s law firm, was pleased to advise the 10.5% noteholder of the Seven Energy Group in relation to the 2019 Seven Energy debt restructuring.  A complex and noteworthy matter, the transaction received recognition at the IFLR Sub-Saharan Africa Awards, winning Restructuring Deal of the Year 2020. 

Read more

14 Sep 2020

Announcements

Maples Group Partner Wins 'Rising Star' Award at European Women in Business Law Awards

Maples and Calder LLP, the Maples Group's law firm in Dublin, is proud to announce that one of its Partners, Niamh O’Shea, has been recognised as a 'Rising Star' at the Euromoney European Women in Business Law Awards 2020. 

Read more

11 Sep 2020

Announcements

Maples Group Appoints Stephen McLoughlin as Head of Finance Practice in Ireland

Maples and Calder LLP, the Maples Group's law firm in Ireland, is pleased to announce the appointment of Stephen McLoughlin to head of its Finance practice in Ireland, effective 1 July 2020.  Stephen succeeds Nicholas Butcher, Managing Partner of the law firm in Ireland who has been acting as head of the practice for the last 18 months. Nicholas continues in his role as Managing Partner.

Read more

03 Sep 2020

Connect

Want to get in touch ?

Contact Us